Full FDA approval for COVID-19 pill Paxlovid approaches
Pfizer’s COVID-19 pill, Paxlovid, has received another vote of confidence from U.S. health advisers, paving the way for its full regulatory approval by the Food and Drug Administration (FDA). Since receiving emergency use authorization in late 2021, millions of Americans have benefited from this medication. The FDA holds the final decision on granting Pfizer’s drug …